Main
>
ONCOLOGY (**)
>
Breast Cancer>HR+>HER2->MET ***
>
Treatment
>
CH. N. Ribociclib+ **
>
(*) CA Approval Date: 2020. 04.16.
(*) CA Approval Date: 2020. 04.16.'s products
This section has no products